Dark Forest Capital Management »

Summit Therapeutics shares owned by Dark Forest Capital Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Dark Forest Capital Management from 13F filings

Historical chart of Dark Forest Capital Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Dark Forest Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Dark Forest Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3M 112k 20.66
2025-03-31 $1.8M 94k 19.29

More positions owned by Dark Forest Capital Management

Loews Corp Common Stock (L)
Ishares Msci Brazil Etf Reit (EWZ)
Simon Property Group Common Stock (SPG)
Vanguard Ftse Emerging Marke Reit (VWO)
Ishares Msci India Etf Reit (INDA)
Capital One Financial Corp Common Stock (COF)
Booz Allen Hamilton Holdings Reit (BAH)
Goldman Sachs Group Common Stock (GS)
Walmart Common Stock (WMT)
Microsoft Corp Common Stock (MSFT)
Axis Capital Holdings Common Stock (AXS)
Cintas Corp Common Stock (CTAS)
Amazon.com Common Stock (AMZN)
Popular Common Stock (BPOP)
Ss Spdr S&p Biotech Etf Common Stock (XBI)

View all positions for Dark Forest Capital Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics